Normal view
MARC view
- Lupus Erythematosus, Systemic
Entry Topical Term
001 - CONTROL NUMBER
- control field: 124862
003 - CONTROL NUMBER IDENTIFIER
- control field: TR-AnTOB
005 - DATE AND TIME OF LATEST TRANSACTION
- control field: 20190531145902.0
008 - FIXED-LENGTH DATA ELEMENTS
- fixed length control field: 190531naeazcnnbabn zn aaa d
040 ## - CATALOGING SOURCE
- Original cataloging agency: DNLM
- Language of cataloging: eng
- Description conventions: rda
- Transcribing agency: TR-AnTOB
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
- Classification number: WD 380
072 ## - SUBJECT CATEGORY CODE
- Subject category code: C17.
- Subject category code subdivision: 300.
- Subject category code subdivision: 480
072 ## - SUBJECT CATEGORY CODE
- Subject category code: C20.
- Subject category code subdivision: 111.
- Subject category code subdivision: 590
150 ## - HEADING--TOPICAL TERM
- Topical term or geographic name entry element: Lupus Erythematosus, Systemic
450 ## - SEE FROM TRACING--TOPICAL TERM
- Topical term or geographic name entry element: Libman-Sacks Disease
450 ## - SEE FROM TRACING--TOPICAL TERM
- Topical term or geographic name entry element: Lupus Erythematosus Disseminatus
450 ## - SEE FROM TRACING--TOPICAL TERM
- Topical term or geographic name entry element: Systemic Lupus Erythematosus
450 ## - SEE FROM TRACING--TOPICAL TERM
- Control subfield: nnna
- Topical term or geographic name entry element: Disease, Libman-Sacks
450 ## - SEE FROM TRACING--TOPICAL TERM
- Control subfield: nnna
- Topical term or geographic name entry element: Libman Sacks Disease
680 ## - PUBLIC GENERAL NOTE
- Explanatory text: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
